BOBBY™ Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke

Last updated: January 6, 2025
Sponsor: Microvention-Terumo, Inc.
Overall Status: Terminated

Phase

N/A

Condition

Stroke

Thrombosis

Cerebral Ischemia

Treatment

BOBBY™ Balloon Guide Catheter intended for use in neurovascular procedures, performing or as an adjunctive device

Clinical Study ID

NCT05361187
STRAIT
  • Ages 18-85
  • All Genders

Study Summary

Evaluation of the safety and performance of the BOBBY™ Balloon Guide Catheter (BGC) in patients with an acute ischemic stroke treatment, a sudden reduction or termination of the blood circulation of the brain, caused by a clot. Immediate treatment is needed to restore the blood circulation in the brain, performing a mechanical removal of the clot (thrombectomy). To prevent clot particles migrating in other parts of the brain circulation during the thrombectomy, balloon guiding catheters are inserted. The aim of the study is to evaluate the safety and performance of the balloon guide catheter BOBBY™ by collecting information from patients, treated with a mechanical thrombectomy and the balloon guide catheter (BOBBY™) after acute ischemic stroke

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient is ≥ 18 and ≤ 85 years of age

  • Informed consent by the patient or legal authorized representative for datacollection is obtained

  • Patient eligible for the mechanical thrombectomy treatment with adjunctive use ofthe BOBBY™ BGC

  • Patient presenting with an anterior circulation large-vessel occlusion of distalinternal carotic artery (ICA ) through proximal M2 confirmed by computed tomographangiography (CTA), magnetic resonance angiography (MRA), or digital subtractionangiography (DSA).

  • Core-infarct volume of Alberta Stroke Program Early CT Score (ASPECTS) ≥ 6 based onbaseline CT or MR imaging

  • Treatment initiated (groin puncture) within 8 hours of symptom onset.

  • Patient with a pre-treatment National Institutes of Health Stroke Scale (NIHSS)score ≥5

  • Patient with no personal condition disabling the site to contact him/her at 90 daysafter procedure

Exclusion

Exclusion Criteria:

  • Patient has evidence of cerebral ischemia in the posterior circulation

  • Patient presents severe unilateral or bilateral carotid artery stenosis requiringstent treatment during the procedure

  • Pregnancy or breastfeeding

  • Patient presents other serious medical illness (e.g., cancer) with estimated lifeexpectancy of less than 3 months

  • Patient has a planned procedure that may cause non-compliance with the protocol orconfound data interpretation

  • Patient is already participating in an investigational drug or device trial (changeroutine care of the patient)

  • Patient has evidence of intracerebral hemorrhage on initial imaging

  • Patient has a significant mass effect with midline shift

Study Design

Total Participants: 171
Treatment Group(s): 1
Primary Treatment: BOBBY™ Balloon Guide Catheter intended for use in neurovascular procedures, performing or as an adjunctive device
Phase:
Study Start date:
April 08, 2022
Estimated Completion Date:
December 30, 2023

Study Description

The main objective of the STRAIT study is to assess the performance of the mechanical thrombectomy using a BOBBY™ Balloon Guide Catheter (BGC) as adjunctive device for endovascular treatment of patients suffering from an anterior circulation acute ischemic stroke. Interventional procedures and clinical follow-up will be performed per standard of care. Patient health-related and imaging data will be collected as of stroke onset time up to 90 days follow up.

Connect with a study center

  • Neuro-Kopf-Zentrum Klinikum rechts der Isar der Technischen Universität München

    Munich, Bayern
    Germany

    Site Not Available

  • Martin Luther Universität Halle

    Halle(Saale), Halle 06120
    Germany

    Site Not Available

  • Neurologische Klinik Abteilung für Neuroradiologie

    Heidelberg,
    Germany

    Site Not Available

  • Klinikum Ingolstadt, Zentrum für Radiologie und Neuroradiologie

    Ingolstadt,
    Germany

    Site Not Available

  • Universitätsklinikum Schleswig-Holstein Campus Kiel

    Kiel,
    Germany

    Site Not Available

  • Department of Neuroradiology, University Hospital of Paracelsus Medical Private University

    Nürnberg,
    Germany

    Site Not Available

  • Devision Neuroradiology, Kantonsspital Aarau

    Aarau,
    Switzerland

    Site Not Available

  • Centre Hospitalier Universitaire Vaudois (CHUV)

    Lausanne,
    Switzerland

    Site Not Available

  • Department of Neuroradiology, University hospital Zürich

    Zürich,
    Switzerland

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.